Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Ahead of Print / In Press

Disclaimer: Ahead of print articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 24, Number 8—August 2018


  • Diphyllobothriasis Status and Perspectives, Japan, 2018
    H. Ikuno et al.
  • Brucellosis in Dogs and Public Health Risk
    M. E. Hensel et al.
  • Abnormal Helminth Egg Development, Strange Morphology, and the Identification of Intestinal Helminth Infections
    S. Sapp et al.
  • Case Series of Severe Neurologic Sequelae of Ebola Virus Disease during Epidemic, Sierra Leone
    P. J. Howlett et al.


  • Hypoglycemic Toxins and Enteroviruses as Causes of Acute Encephalitis-Like Syndrome in Children, Bac Giang Province, Northern Vietnam
    N. Phan et al.
  • Treating Myanmar Refugees with Ancylostoma ceylanicum, Thailand-Myanmar Border, 2012–2015
    E. M. O’Connell et al.
  • Clonal Expansion of Macrolide-Resistant Sequence Type 3 Mycoplasma pneumoniae, South Korea
    J. Lee et al.
  • Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
    F. Robert-Gangneux et al.
  • Susceptibility of Human Prion Protein to Conversion by Chronic Wasting Disease Prions
    M. A. Barria et al.
  • Enhanced Surveillance for Coccidioidomycosis, 14 U.S. States, 2016
    K. Benedict et al.
  • Novel Enterobacter Lineage as Leading Cause of Nosocomial Outbreak Involving Carbapenemase-Producing Strains
    R. Beyrouthy et al.


  • Therapeutic and Transmission-Blocking 
Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
    J. Popovici et al.
        View Abstract

    We assessed the efficacy of standard 3-day courses of chloroquine and dihydroartemisinin/piperaquine against Plasmodium vivax malaria. Compared with chloroquine, dihydroartemisinin/piperaquine was faster in clearing asexual P. vivax parasites and blocking human-to-mosquito transmission. This drug combination was also more effective in preventing potential recurrences for >2 months.

        Email Email this Article
  • Dual Genotype Infection of Orientia tsutsugamushi in Patient with Rash and Eschar, Vietnam
    N. Le-Viet et al.
  • Coxiella burnetii Endocarditis and Meningitis in Man
    L. Allan-Blitz et al.
  • Anncaliia algerae microsporidial Myositis, South Wales, United Kingdom
    G. Sutrave et al.
  • Hospitalized Patient as Source of Aspergillus fumigatus, 2015
    B. Lemaire et al.
  • Probable Locally Acquired Babesia divergens–Like Infection in Woman, Michigan, USA
    E. Herc et al.
  • Variation in Influenza B Virus Epidemiology by Lineage, China
    J. Yang et al.
  • Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab
    D. Nolfi-Donegan et al.
  • Dengue Virus Detected among Children in whom Malaria was Suspected by using a Multiple-pathogen Assay, Accra, Ghana
    N. Amoako et al.
  • Outbreak of Trichinella T9 Infections Associated with Consumption of Bear Meat, Japan
    K. Tada et al.
  • Invasive Colonic Entamoebiasis in Wild Cane Toads, Australia
    C. M. Shilton et al.
  • Direct Detection of the penA gene Associated with Ceftriaxone-resistant Neisseria gonorrhoeae FC428 Strain by Using PCR
    D. M. Whiley et al.

Research Letters

  • Piperaquine Resistance in Plasmodium falciparum, West Africa
    J. Inoue et al.
        View Abstract

    Dihydroartemisinin/piperaquine (DHA/PPQ) is increasingly deployed as antimalaria drug in Africa. We report the detection in Mali of Plasmodium falciparum infections carrying plasmepsin 2 duplications (associated with piperaquine resistance) in 7/65 recurrent infections within 2 months after DHA/PPQ treatment. These findings raise concerns about the long-term efficacy of DHA/PPQ treatment in Africa.

        Email Email this Article
  • Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
    M. Ahle et al.
  • Dapsone Resistance in Leprosy Patients Originally from American Samoa, USA
    D. Williams et al.
  • Babesiosis Misdiagnosed as Malaria, Equatorial Guinea, 2014
    M. Arsuaga et al.
  • Phylogeny of Yellow Fever Virus, Uganda, 2016
    H. R. Hughes et al.
        View Abstract

    In April 2016, a yellow fever outbreak was detected in Uganda. Removal of contaminating ribosomal RNA in a clinical sample improved the sensitivity of next-generation sequencing. Molecular analyses determined the Uganda yellow fever outbreak was distinct from the concurrent yellow fever outbreak in Angola, improving our understanding of yellow fever epidemiology.

        Email Email this Article
  • Paenibacillus assamensis in Joint Fluid of Man with Suspected Tularemia, China
    E. Zhang et al.


  • Visceral Leishmaniasis in Traveler to Guyana Caused by Leishmania siamensis, London, UK
    J. Depaquit et al.
  • Visceral Leishmaniasis in Traveler to Guyana Caused by Leishmania siamensis, London, UK
    S. Leelayoova et al.

Online Report

  • Case Definition of Chronic Pulmonary Aspergillosis in Resource-Limited Settings
    D. W. Denning et al.

Volume 24, Number 9—September 2018


  • National Surveillance for Clostridium difficile Infection, Sweden, 2009–2016
    K. Rizzardi et al.
  • Travel-Associated Zika Cases and Threat of Local Transmission during Global Outbreak, California, USA
    C. Porse et al.
  • Systematic Review and Meta-Analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Infection among Healthcare Workers
    Ö. Ergönül et al.


  • Novel Orthopoxvirus and Lethal Disease in Cat, Italy
    G. Lanave et al.


  • Endemicity of Zika Virus in Indonesia
    R. Sasmono et al.
  • Batai Virus Infection and Encephalitis in Harbor Seals, Germany, 2016
    W. K. Jo et al.
  • Susceptibility of White-Tailed Deer to Rift Valley Fever Virus
    W. C. Wilson et al.
  • Use of Favipiravir to Treat Lassa Virus Infection in Macaques
    K. Rosenke et al.
        View Abstract

    Lassa virus, the cause of Lassa fever in humans, is endemic to West Africa. Treatment of Lassa fever is primarily supportive, although ribavirin has shown limited efficacy if administered early during infection. We tested favipiravir in Lassa virus–viremic macaques and found that 300 mg/kg daily for 2 weeks successfully treated infection.

        Email Email this Article
  • Estimating Frequency of Probable Autochthonous Cases of Dengue, Japan
    A. Senda et al.
  • Molecular Confirmation of Rocky Mountain Spotted Fever Epidemic Agent in Mexicali, Mexico
    L. Tinoco-Gracia et al.

Research Letters

  • Transverse Myelitis and Guillain-Barré Syndrome Associated with Cat-Scratch Disease, Texas, USA
    R. Zakhour et al.
  • Travelers’ Actual and Subjective Knowledge about Risk for Ebola Virus Disease
    I. Régner et al.

Volume 24, Number 10—October 2018


  • Molecular Evolution, Diversity, and Adaptation of Influenza A(H7N9) Viruses in China
    J. Lu et al.
  • Influenza Transmission Dynamics in Nicaragua Households
    A. Gordon et al.

Online Report

  • Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016–17
    C. Adlhoch et al.